Efficacy News and Research

RSS
Positive results from Palatin’s bremelanotide Phase 2B trial on female sexual dysfunction

Positive results from Palatin’s bremelanotide Phase 2B trial on female sexual dysfunction

Community-based brain injury education program may increase children's use of bicycle helmets

Community-based brain injury education program may increase children's use of bicycle helmets

FDA accepts Merck’s suvorexant NDA for standard review

FDA accepts Merck’s suvorexant NDA for standard review

Stapled Peptide oncology drug candidate exhibits robust efficacy in xenograft cancer models

Stapled Peptide oncology drug candidate exhibits robust efficacy in xenograft cancer models

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

EpiCept, Immune Pharmaceuticals enter definitive merger agreement

EpiCept, Immune Pharmaceuticals enter definitive merger agreement

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Teva announces additional data from QNASL Phase III program on seasonal allergic rhinitis

Arisaph’s ARI-3037MO well tolerated in healthy male and female volunteers

Arisaph’s ARI-3037MO well tolerated in healthy male and female volunteers

Treatment with AMG 145 reduces LDL cholesterol

Treatment with AMG 145 reduces LDL cholesterol

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

Positive results from Santarus and Pharming’s RUCONEST Phase III trial on HAE

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Lexicon announces data from LX4211 Phase 2b trial on type 2 diabetes

Lexicon announces data from LX4211 Phase 2b trial on type 2 diabetes

Positive results from BioCardia's Helical Infusion System Phase 1/2 trial on ischemic cardiomyopathy

Positive results from BioCardia's Helical Infusion System Phase 1/2 trial on ischemic cardiomyopathy

Cryopraxis/CellPraxis initiates recruitment in ReACT Phase III trial for refractory angina

Cryopraxis/CellPraxis initiates recruitment in ReACT Phase III trial for refractory angina

Receptor expression sheds light on nasal polyposis

Receptor expression sheds light on nasal polyposis

Physical exercise may help preserve mobility in Parkinson’s patients

Physical exercise may help preserve mobility in Parkinson’s patients

Alnylam third quarter 2012 revenues decrease to $16.8 million

Alnylam third quarter 2012 revenues decrease to $16.8 million

Sapacitabine tolerated, efficacious in elderly leukemia patients

Sapacitabine tolerated, efficacious in elderly leukemia patients

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

PsiOxus receives UK government grant to initiate ColoAd1 Phase I/II trial for ovarian cancer

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.